Carotid in-stent restenosis associated with stent fracture and migration

2006 ◽  
Vol 7 (2) ◽  
pp. 119-120 ◽  
Author(s):  
Z. N'Dandu ◽  
S. Arain ◽  
S. Ramee
Keyword(s):  
Stent Fracture ◽  
Stent Restenosis ◽  
And Migration ◽  
In Stent Restenosis

scholarly journals Inhibition of in-stent restenosis after graphene oxide double-layer drug coating with good biocompatibility

2019 ◽  
Vol 6 (5) ◽  
pp. 299-309 ◽  
Author(s):  
Shuang Ge ◽  
Yadong Xi ◽  
Ruolin Du ◽  
Yuzhen Ren ◽  
Zichen Xu ◽  
...  
Keyword(s):  
Graphene Oxide ◽  
Double Layer ◽  
Toxicity Tests ◽  
Spray System ◽  
Stent Restenosis ◽  
Ultrasonic Spray ◽  
Before And After ◽  
Coated Surface ◽  
And Migration ◽  
In Stent Restenosis

Abstract In this study, we designed a double layer-coated vascular stent of 316L stainless steel using an ultrasonic spray system to achieve both antiproliferation and antithrombosis. The coating included an inner layer of graphene oxide (GO) loaded with docetaxel (DTX) and an outer layer of carboxymethyl chitosan (CMC) loaded with heparin (Hep). The coated surface was uniform without aggregation and shedding phenomena before and after stent expanded. The coating treatment was able to inhibit the adhesion and activation of platelets and the proliferation and migration of smooth muscle cells, indicating the excellent biocompatibility and antiproliferation ability. The toxicity tests showed that the GO/DTX and CMC/Hep coating did not cause deformity and organ abnormalities in zebrafish under stereomicroscope. The stents with GO double-layer coating were safe and could effectively prevent thrombosis and in-stent restenosis after the implantation into rabbit carotid arteries for 4–12 weeks.

Coronary artery stent fracture with aneurysm formation and in-stent restenosis

2010 ◽  
Vol 140 (2) ◽  
pp. e36-e39 ◽  
Author(s):  
Šime Manola ◽  
Hrvoje Pintarić ◽  
Nikola Pavlović ◽  
Krešimir Štambuk
Keyword(s):  
Coronary Artery ◽  
Stent Fracture ◽  
Aneurysm Formation ◽  
Coronary Artery Stent ◽  
Stent Restenosis ◽  
In Stent Restenosis

Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents

2009 ◽  
Vol 20 (1) ◽  
pp. 59-63 ◽  
Author(s):  
Jung-Sun Kim ◽  
Seung-Yul Lee ◽  
Jung Myung Lee ◽  
Young Won Yoon ◽  
Chul-Min Ahn ◽  
...  
Keyword(s):  
Coronary Stent ◽  
Stent Fracture ◽  
Stent Restenosis ◽  
In Stent Restenosis

scholarly journals Mechanical Performance of PLLA Stent

2018 ◽  
Author(s):  
Longzhen Wang ◽  
Junfei Tong ◽  
Pengfei Dong ◽  
David L. Wilson ◽  
Hiram G. Bezerra ◽  
...  
Keyword(s):  
Mechanical Performance ◽  
Metal Alloys ◽  
Stent Fracture ◽  
Stent Restenosis ◽  
Biodegradable Stents ◽  
Plla Stent ◽  
One Year ◽  
In Stent Restenosis ◽  
Cobalt Chrome

Stent implantation is widely used to treat blocked lumen. Stents were meshed structure made of polymers and metal alloys, including stainless steel, cobalt chrome and nitinol [1]. Clinical studies had demonstrated that stents helped to scaffold the diseased lesion up to one year when tissue adapted to the stented environment [2]. However, the permanently implanted stents inside artery were associated with complications such as stent fracture, tissue inflammation, in-stent restenosis and thrombosis [3]. Currently, biodegradable stents are attracting more attention due to its potential long-term efficacy in treating blocked lumens. The detailed characterizations of biodegradable stents are essential for the desired clinical outcomes.

Stent fracture and restenosis after placement of a drug-eluting device in the vertebral artery origin and treatment with the stent-in-stent technique

2007 ◽  
Vol 106 (5) ◽  
pp. 907-911 ◽  
Author(s):  
Seong-Rim Kim ◽  
Min-Woo Baik ◽  
Seung-Hoon Yoo ◽  
Ik-Seong Park ◽  
Sang-Don Kim ◽  
...  
Keyword(s):  
Vertebral Artery ◽  
Stent Placement ◽  
Coronary Stents ◽  
Drug Eluting Stent ◽  
Stent Fracture ◽  
Stent Restenosis ◽  
Stent Strut ◽  
Drug Eluting ◽  
In Stent Restenosis

✓ The authors report two cases of stent fracture and restenosis after placement of a drug-eluting device in the vertebral artery (VA) origin, and describe management of restenosis with the stent-in-stent technique. Two women, one 62 and the other 67 years of age, underwent stent placement in the VA origin to treat symptomatic and angiographically significant stenosis in this vessel. Sirolimus-eluting coronary stents (Cypher) were used in both cases. Four months after placement of the devices, the symptoms recurred. Follow-up angiography performed 5 months after insertion of the devices revealed a transverse stent fracture with separation of the fragments and severe in-stent restenosis in both cases. The restenoses were treated with reinsertion of coronary stents (Cypher and Jostent FlexMaster) by using the stent-in-stent technique. After stent reinsertion, the patients exhibited relief of symptoms. This paper is the first report of fracture in a drug-eluting stent and restenosis after stent placement in the VA origin. Restenosis caused by such a fracture can be managed successfully by performing the stent-in-stent maneuver. The physical properties of metallic devices, stent strut geometry, and anatomical peculiarities of the subclavian artery may be associated with stent fractures. Earlier follow-up angiography studies (within 6 months) are warranted.

scholarly journals Peri-Contrast Staining as a Marker of Stent Failure: Restenosis, Thrombosis, and Fracture

2021 ◽  
Vol 2021 ◽  
pp. 1-4
Author(s):  
Fakilahyel S. Mshelbwala ◽  
Mir B. Basir ◽  
Brittany Fuller ◽  
Khaldoon Alaswad
Keyword(s):  
Stent Thrombosis ◽  
First Generation ◽  
Coronary Aneurysm ◽  
Target Lesion ◽  
Stent Fracture ◽  
Coronary Angiogram ◽  
Stent Restenosis ◽  
Artery Disease ◽  
In Stent Restenosis

The introduction of stents has led to significant improvement in the management of coronary artery disease. In-stent thrombosis, target lesion revascularization, and stent fracture (SF) have been identified as causes of in-stent restenosis. Peri-contrast staining (PSS) has been associated with in-stent restenosis, stent thrombosis, stent fracture, and the development of coronary aneurysm. As the frequency of patients with first generation sirolimus-eluting coronary stents becomes infrequent; PSS may go unrecognized. Herein, we present a patient with a decade of longitudinal follow-up, who developed PSS identified on coronary angiogram with recurrent stent failure.

Long-Term Risk of In-Stent Restenosis and Stent Fracture for Extracranial Vertebral Artery Stenting

2018 ◽  
Vol 29 (4) ◽  
pp. 701-706 ◽  
Author(s):  
Man Kwun Andrew Li ◽  
Anderson Chun On Tsang ◽  
Frederick Chun Pong Tsang ◽  
Wai Shing Ho ◽  
Raymand Lee ◽  
...  
Keyword(s):  
Vertebral Artery ◽  
Stent Fracture ◽  
Stent Restenosis ◽  
Extracranial Vertebral Artery ◽  
Vertebral Artery Stenting ◽  
In Stent Restenosis
Sign in / Sign up

Export Citation Format

Share Document